Marlborough

Boston Scientific has completed its acquisition of a division of the Lowell-based electrophysiology business of C.R. Bard, which the Natick-based medical device manufacturer said could significantly boost its capabilities in the fast-growing market for advanced electrophysiology procedures.

The U.S. Food and Drug Administration has asked Marlborough-based Sunovion Pharmaceuticals Inc. to stop distributing promotional brochures for respiratory drug Brovana that it considers deceptive, according to a letter released Tuesday.

UMass Memorial Health Care is bracing for layoffs as well as other cost-cutting measures in the face of a projected $57-million operating loss for its recently completed fiscal year.

A day after it said it would cut up to 1,500 jobs over the next two years, and on the same day it announced a third-quarter loss of $5 million, Boston Scientific said its chief financial officer will leave after the end of the year.

Three of the least safe Bay State hospitals are located in Central Massachusetts, according to a report compiled Wednesday by a nonprofit.

A housing developer paid $14.88 million Monday to buy a 23.5 acre parcel in Marlborough where it plans to build 350 apartments.

Content security provider Content Raven of Marlborough has signed a reseller agreement with a Japanese company that will use Content Raven's software as part of its cloud-based file sharing and transfer service.

Quest Diagnostics, which increased its presence in Central Massachusetts within the last year, reported a 2-percent drop in revenue for its most recent quarter, and lowered revenue expectations by 3.5 percent for the year, the New Jersey-based medical laboratories services provider announced.

Raytheon Co. has been awarded up to $1.63 billion from the U.S. Navy to build and deliver next-generation air and missile defense radar, the company said.

Verax Biomedical announced the completion of a $12 million round of financing to support the ongoing commercialization of its product, the Platelet PGD Test.